Development of an Antioxidant Phytoextract ofLantana grisebachiiwith Lymphoprotective Activity againstIn VitroArsenic Toxicity
[摘要] Phytochemicals have been presumed to possess prophylactic and curative properties in several pathologies, such as arsenic- (As-) induced immunosuppression. Our aim was to discover a lymphoprotective extract fromLantana grisebachiiStuck. (Verbenaceae) (LG). We assessed its bioactivity and chemical composition using cell-based assays. Fractions produced from a hexane extract acutely induced nitrite formation in T-activated cell culturesP<0.0001. Water extraction released a fraction lacking nitrite inducing activity in both lymphocyte types. Aqueous LG was found to be safe in proliferated and proliferating cells. The infusion-derived extract presented better antioxidant capacity in proportion to phenolic amount in lymphocytes (infusive LG-1i at 100 μg/mL), which protected them againstin vitroAs-induced lymphotoxicityP<0.0001. This infusive LG phytoextract contained10.23±0.43 mg/g of phenolics, with 58.46% being flavonoids. Among the phenolics, the only predominant compound was 0.723 mg of chlorogenic acid per gram of dry plant, in addition to 10 unknown minor compounds. A fatty acid profile was assessed. It contained one-third of saturated fatty acids, one-third ofω9, followed byω6 (~24%) andω3 (~4%), and scarceω7. Summing up,L. grisebachiiwas a source of bioactive and lymphoprotective compounds, which could counteract As-toxicity. This supports its phytomedical use and research in order to reduce As-related dysfunctions.
[发布日期] [发布机构]
[效力级别] [学科分类] 药学
[关键词] [时效性]